Novavax Researcher Says No Chance Of A 'Shortcut' In Vaccine Safety

Three potential coronavirus vaccines are kept in a tray at Novavax labs in Gaithersburg, Md., in March 2020. The company has moved into phase 3 trials in the U.K.

Vaccine maker Novavax is starting a large coronavirus vaccine trial in the U.K. Gregory Glenn, the company's president of research and development, talks with NPR about how vaccines are tested.

(Image credit: Andrew Caballero-Reynolds/AFP via Getty Images)

Comments

Popular posts from this blog

FIVE SIGNS YOUR TEEN MAY NEED TO BE EVALUATED FOR DEPRESSION

TAKE ACTION TO STOP BULLYING

GETTING BACK TO SCHOOL SAFELY